A detailed history of Steward Financial Group LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Financial Group LLC holds 46 shares of REGN stock, worth $32,285. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46
Previous 45 2.22%
Holding current value
$32,285
Previous $32,000 15.63%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$692.45 - $844.37 $692 - $844
1 Added 2.22%
46 $37,000
Q2 2023

Aug 04, 2023

SELL
$700.03 - $830.35 $8,400 - $9,964
-12 Reduced 21.05%
45 $32,000
Q1 2023

May 05, 2023

BUY
$680.49 - $826.97 $12,248 - $14,885
18 Added 46.15%
57 $46,000
Q4 2022

Feb 13, 2023

BUY
$705.89 - $766.39 $27,529 - $29,889
39 New
39 $28,000
Q2 2022

Jul 22, 2022

BUY
$548.35 - $738.84 $4,935 - $6,649
9 Added 30.0%
39 $23,000
Q1 2022

May 03, 2022

BUY
$595.12 - $698.43 $17,853 - $20,952
30 New
30 $20,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.